All patients | Type of IED at index date | ||||||
---|---|---|---|---|---|---|---|
Group 1 | Group 2 | P-value | Group 1 with sepsis | Group 2 | P-value | ||
N = 19,773 | N = 10,235 | N = 9,538 | N = 5,978 | N = 9,538 | |||
Demographic characteristics | |||||||
Age, mean ± SD [median] | 76.8 ± 8.9 [77.0] | 75.9 ± 8.9 [76.0] | 77.8 ± 8.8 [79.0] | < 0.0001 | 76.2 ± 8.9 [76.0] | 77.8 ± 8.8 [79.0] | < 0.0001 |
< 65 years old, n (%) | 2,231 (11.3) | 1,336 (13.1) | 895 (9.4) | < 0.0001 | 735 (12.3) | 895 (9.4) | < 0.0001 |
65–74 years old, n (%) | 5,876 (29.7) | 3,326 (32.5) | 2,550 (26.7) | < 0.0001 | 1,898 (31.7) | 2,550 (26.7) | < 0.0001 |
75–84 years old, n (%) | 6,510 (32.9) | 3,256 (31.8) | 3,254 (34.1) | 0.0006 | 1,936 (32.4) | 3,254 (34.1) | 0.0262 |
≥ 85 years old, n (%) | 5,156 (26.1) | 2,317 (22.6) | 2,839 (29.8) | < 0.0001 | 1,409 (23.6) | 2,839 (29.8) | < 0.0001 |
Gender, n (%) | |||||||
Female | 13,321 (67.4) | 6,016 (58.8) | 7,305 (76.6) | < 0.0001 | 3,390 (56.7) | 7,305 (76.6) | < 0.0001 |
Male | 6,451 (32.6) | 4,219 (41.2) | 2,232 (23.4) | < 0.0001 | 2,588 (43.3) | 2,232 (23.4) | < 0.0001 |
Unknown | 1 (0.0) | 0 (0.0) | 1 (0.0) | - | 0 (0.0) | 1 (0.0) | - |
Race, n (%) | |||||||
White | 16,234 (82.1) | 8,302 (81.1) | 7,932 (83.2) | 0.0002 | 4,768 (79.8) | 7,932 (83.2) | < 0.0001 |
Black | 1,799 (9.1) | 831 (8.1) | 968 (10.1) | < 0.0001 | 535 (8.9) | 968 (10.1) | 0.0140 |
Asian | 646 (3.3) | 434 (4.2) | 212 (2.2) | < 0.0001 | 284 (4.8) | 212 (2.2) | < 0.0001 |
Other | 909 (4.6) | 569 (5.6) | 340 (3.6) | < 0.0001 | 339 (5.7) | 340 (3.6) | < 0.0001 |
Unknown | 185 (0.9) | 99 (1.0) | 86 (0.9) | 0.6320 | 52 (0.9) | 86 (0.9) | 0.8373 |
Comorbidities | |||||||
CCI score,amean ± SD [median] | 2.5 ± 2.1 [2.0] | 2.2 ± 2.1 [2.0] | 2.8 ± 2.1 [2.0] | < 0.0001 | 2.5 ± 2.2 [2.0] | 2.8 ± 2.1 [2.0] | < 0.0001 |
≥ 3, N (%) | 8,398 (42.5) | 3,730 (36.4) | 4,668 (48.9) | < 0.0001 | 2,555 (42.7) | 4,668 (48.9) | < 0.0001 |
CCI comorbiditiesb | |||||||
AIDS/HIV | 21 (0.1) | 9 (0.1) | 12 (0.1) | 0.4139 | 7 (0.1) | 12 (0.1) | 0.8799 |
Cancer | 2,102 (10.6) | 1,217 (11.9) | 885 (9.3) | < 0.0001 | 765 (12.8) | 885 (9.3) | < 0.0001 |
Any malignancy, including lymphoma and leukemia except malignant neoplasm of the skin | 1,295 (6.5) | 793 (7.7) | 502 (5.3) | < 0.0001 | 492 (8.2) | 502 (5.3) | < 0.0001 |
Metastatic solid tumor | 807 (4.1) | 424 (4.1) | 383 (4.0) | 0.6516 | 273 (4.6) | 383 (4.0) | 0.0968 |
Cerebrovascular disease | 1,811 (9.2) | 626 (6.1) | 1,185 (12.4) | < 0.0001 | 426 (7.1) | 1,185 (12.4) | < 0.0001 |
Chronic pulmonary disease | 5,036 (25.5) | 2,324 (22.7) | 2,712 (28.4) | < 0.0001 | 1,421 (23.8) | 2,712 (28.4) | < 0.0001 |
Congestive heart failure | 5,803 (29.3) | 2,565 (25.1) | 3,238 (33.9) | < 0.0001 | 1,762 (29.5) | 3,238 (33.9) | < 0.0001 |
Dementia | 4,465 (22.6) | 1,536 (15.0) | 2,929 (30.7) | < 0.0001 | 1,014 (17.0) | 2,929 (30.7) | < 0.0001 |
Diabetes without chronic complications | 4,266 (21.6) | 2,243 (21.9) | 2,023 (21.2) | 0.2284 | 1,345 (22.5) | 2,023 (21.2) | 0.0580 |
Diabetes with complications | 3,992 (20.2) | 1,782 (17.4) | 2,210 (23.2) | < 0.0001 | 1,226 (20.5) | 2,210 (23.2) | 0.0001 |
Hemiplegia or paraplegia | 427 (2.2) | 131 (1.3) | 296 (3.1) | < 0.0001 | 95 (1.6) | 296 (3.1) | < 0.0001 |
Mild liver disease | 890 (4.5) | 531 (5.2) | 359 (3.8) | < 0.0001 | 381 (6.4) | 359 (3.8) | < 0.0001 |
Moderate or severe liver disease | 430 (2.2) | 242 (2.4) | 188 (2.0) | 0.0581 | 197 (3.3) | 188 (2.0) | < 0.0001 |
Myocardial infarction | 2,942 (14.9) | 1,404 (13.7) | 1,538 (16.1) | < 0.0001 | 979 (16.4) | 1,538 (16.1) | 0.6789 |
Peptic ulcer disease | 360 (1.8) | 139 (1.4) | 221 (2.3) | < 0.0001 | 109 (1.8) | 221 (2.3) | 0.0380 |
Peripheral vascular disease | 2,066 (10.4) | 928 (9.1) | 1,138 (11.9) | < 0.0001 | 604 (10.1) | 1,138 (11.9) | 0.0004 |
Renal disease | 6,529 (33.0) | 3,019 (29.5) | 3,510 (36.8) | < 0.0001 | 2,034 (34.0) | 3,510 (36.8) | 0.0004 |
Rheumatic disease | 933 (4.7) | 482 (4.7) | 451 (4.7) | 0.9495 | 276 (4.6) | 451 (4.7) | 0.7490 |
Other selected comorbiditiesb | |||||||
Cataracts | 95 (0.5) | 42 (0.4) | 53 (0.6) | 0.1398 | 23 (0.4) | 53 (0.6) | 0.1378 |
Glaucoma | 625 (3.2) | 277 (2.7) | 348 (3.6) | 0.0002 | 167 (2.8) | 348 (3.6) | 0.0038 |
Hearing problems | 759 (3.8) | 349 (3.4) | 410 (4.3) | 0.0012 | 207 (3.5) | 410 (4.3) | 0.0095 |
High blood pressure | 15,849 (80.2) | 7,974 (77.9) | 7,875 (82.6) | < 0.0001 | 4,790 (80.1) | 7,875 (82.6) | 0.0001 |
Migraine/headache | 392 (2.0) | 224 (2.2) | 168 (1.8) | 0.0313 | 111 (1.9) | 168 (1.8) | 0.6633 |
Kidney stone | 597 (3.0) | 403 (3.9) | 194 (2.0) | < 0.0001 | 259 (4.3) | 194 (2.0) | < 0.0001 |
Benign prostate hyperplasia | 2,086 (10.5) | 1,294 (12.6) | 792 (8.3) | < 0.0001 | 813 (13.6) | 792 (8.3) | < 0.0001 |
Hospital characteristics | |||||||
Number of beds, n (%) | |||||||
≥ 500 | 6,032 (30.5) | 2,972 (29.0) | 3,060 (32.1) | < 0.0001 | 1,792 (30.0) | 3,060 (32.1) | 0.0059 |
Region, n (%) | |||||||
Midwest | 4,721 (23.9) | 2,386 (23.3) | 2,335 (24.5) | 0.0540 | 1,395 (23.3) | 2,335 (24.5) | 0.1042 |
Northeast | 3,271 (16.5) | 1,826 (17.8) | 1,445 (15.1) | < 0.0001 | 1,089 (18.2) | 1,445 (15.1) | < 0.0001 |
South | 11,046 (55.9) | 5,578 (54.5) | 5,468 (57.3) | < 0.0001 | 3,198 (53.5) | 5,468 (57.3) | < 0.0001 |
West | 735 (3.7) | 445 (4.3) | 290 (3.0) | < 0.0001 | 296 (5.0) | 290 (3.0) | < 0.0001 |
Teaching hospital, n (%) | 7,909 (40.0) | 3,998 (39.1) | 3,911 (41.0) | 0.0053 | 2,411 (40.3) | 3,911 (41.0) | 0.4062 |
Population served, n (%) | |||||||
Urban | 16,638 (84.1) | 8,494 (83.0) | 8,144 (85.4) | < 0.0001 | 5,134 (85.9) | 8,144 (85.4) | 0.3913 |
Rural | 3,135 (15.9) | 1,741 (17.0) | 1,394 (14.6) | < 0.0001 | 844 (14.1) | 1,394 (14.6) | 0.3913 |